The Diagnostic Value of Nitrogen Element (N) in Esophagus Cancer
NCT05494359 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2025-07-14
Summary
The purpose of this study is to determine the diagnostic value of various nitrogen components in oral gas for esophagus cancer (ESCA) .
Conditions
- Esophageal Cancer
Interventions
- DIAGNOSTIC_TEST
-
The nitrogen isotope
The nitrogen mass-charge ratio abundances (NMAs) and NMA ratios (NMARs) The nitrogen components of various m/z values in oral gas were detected.
Sponsors & Collaborators
-
Hepatopancreatobiliary Surgery Institute of Gansu Province
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-04-04
- Primary Completion
- 2024-11-16
- Completion
- 2024-11-16
Countries
- China
Study Locations
More Related Trials
-
Endoscopic Screening on Esophageal Cancer
NCT02094105 ·Status: COMPLETED ·Phase: NA
-
A Phase II Trial to Compare Efficacy and Safety of CRT VS Neo-CRT in Patients Who Achieved CCR for Esophageal Cancer
NCT02959385 ·Status: UNKNOWN ·Phase: PHASE2
-
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
NCT05833594 ·Status: RECRUITING
-
The Efficacy of Immunodetection Point Inhibitors for Advanced Esophageal Cancer
NCT04074447 ·Status: UNKNOWN
-
Investigating the Association Between Microbiota and Esophageal/Oropharyngeal Cancer
NCT05412628 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
NCT05807542 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
NCT02569242 ·Status: COMPLETED ·Phase: PHASE3
-
Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal Cancer
NCT05349045 ·Status: UNKNOWN
-
Monitoring Efficacy of Radiotherapy in Lung Cancer and Esophageal Cancer
NCT04014465 ·Status: UNKNOWN
-
Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years
NCT05604950 ·Status: COMPLETED
-
The Application of 3T MRI in Esophageal Cancer
NCT03635619 ·Status: UNKNOWN
-
Molecular Assessment for Gastro-Esophageal Cancer
NCT06346054 ·Status: RECRUITING ·Phase: NA
-
Precisely Estimation of the Prognostic Value of Lymph Node in ESCC
NCT04764240 ·Status: COMPLETED
-
Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
NCT06509022 ·Status: ENROLLING_BY_INVITATION
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Efficacy and Safety of Neo-CRT Followed Surgery Compared With Definitive CRT in Patients With Initial Unresectable ESO
NCT04137679 ·Status: UNKNOWN ·Phase: PHASE2
-
Endoscopy Screening for Esophageal Cancer
NCT00927446 ·Status: TERMINATED
-
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
NCT01048281 ·Status: RECRUITING
-
ctDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma
NCT05426850 ·Status: UNKNOWN
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Different Cycles of Capecitabine Usage in Esophageal Cancer Concurrent Chemoradiotherapy
NCT02603159 ·Status: UNKNOWN ·Phase: PHASE3
-
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
NCT04001478 ·Status: UNKNOWN
-
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma
NCT02908204 ·Status: UNKNOWN